Skip to main content
News

Optimapharm Further Expands in the US to Enhance Customer Collaboration

By October 28, 2022May 2nd, 2023No Comments

Optimapharm Further Expands in the US to Enhance Customer Collaboration

We Deliver on
Your Promises

In line with its strategic growth plans, Optimapharm has opened a new office in Boston, Massachusetts this September. The role of this office will be to further support our current operations in North America and to ensure continued excellence in delivery to our existing and future clients.

“As we continue to expand our mid-market offering, we look forward to joining the life-sciences ecosystem of the very dynamic Boston area! Our investment into the region, supported by our talented team, significantly enhances Optimapharm’s delivery capabilities,” said Ivana Waller, CEO of Optimapharm

ABOUT OPTIMAPHARM

Founded in 2006, Optimapharm, with 27 offices in Europe and North America, operates in more than 40 countries. Optimapharm is a mid-market CRO providing full-service solutions and unrivalled access to patients and Investigators, covering markets with a total population of over 900 million people. Optimapharm conducts phase I –IV studies in all therapeutic areas with a specific focus on Oncology, Neurosciences, Cardio-endocrinology-metabolic, and infectious diseases. With very strong operational teams, Optimapharm is also a leading CRO for Medical Device companies and has a reputation for excellence in rescuing studies.

Optimapharm USA Inc. 800 Boylston Street | Prudential Tower, 16th Floor | Boston, Massachusetts | 02199 |
United States of America. contact@optimapharm.eu

Download PDF

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs

REQUEST PROPOSAL
“

I would like to thank you all for the tremendous work done to reach this important milestone for the study in a very challenging and complex global environment. It is the first of many others that we will have to achieve together. Let's keep it up!

Clinical Project Leader, Big Pharma Company
“

We are very grateful for your hard work and dedication over the past few years. We are delighted to be part of this partnership and look forward to start treating patients in this new therapeutic area soon. We could not have done this without your contribution. We are very excited about the path ahead and can hardly wait to start this study.

Chief Executive Officer, Biotech Company
“

Corporate team and I would like to sincerely thank all the team members, both global and local, as well as the site staff, who have worked extremely hard to reach this lock! This has been achieved under difficult circumstances, being significantly earlier than planned for this discontinued study and in the middle of the COVID-19 pandemic with lockdowns or curfews in place in many of the countries. A huge thank you to all for your team spirit and commitment to reach this goal!

Clinical Project Lead, Big Pharma Company
“

Very pleased. Looking forward to getting the country up and running soon.

VP Global Clinical Operations, Medical Device Company

Let's talk about your study needs 

REQUEST PROPOSAL
Privacy policy »
GDPR information »
Cookie policy »
Corporate information »
Head Office
Almeria Business Tower
Ulica grada Vukovara 284
10000 Zagreb, Croatia
T: +385-1-560 3600
© 2024 Optimapharm.
All rights reserved
Interested in a career with us?
View current opportunities »

 

Connect with us »
Optimapharm